New ultrasound could predict Baby's lung health
NCT ID NCT06722365
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a special type of ultrasound, called backscatter quantitative ultrasound (bQUS), to see if it can be used to check on a baby's lungs when the mother is 36 weeks pregnant. The study will involve 16 pregnant women who will have a single 30-minute ultrasound. The goal is to see if this technique is feasible and to gather initial data on fetal lung structure.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a non-invasive way to assess fetal lung development before birth.
- What could go wrong
- This is a very small, early feasibility study with only 16 participants. The technique may not work as expected, and the study may be stopped early if technical issues arise.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 16 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2024
- Expected to finish
-
Jun 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Pregnant females ages 18 to 45 years old with singleton pregnancy, live fetus, gestational age between 32.1 and 36.7 weeks, not in labor, scheduled for routine ultrasound growth evaluation
- Ages
-
18 to 45 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Pregnant females ages 18 to 45 years old with singleton pregnancy, live fetus, gestational age between 32.1 and 36.7 weeks, not in labor, scheduled for routine ultrasound growth evaluation. * Gestational age determined by the date of the last menses, and confirmed by measurement of the crown-rump-length on transabdominal ultrasound. Exclusion Criteria: * Subjects unable to consent * Active Labor * Fetal malformations of the lungs * Prescription of corticosteroids prior to ultrasound evaluation * Pre-gestation or gestational diabetes mellitus * Low English proficiency, needing an interpreter
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Fetal lung imaging are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Meriter Hospital
RECRUITINGMadison, Wisconsin, 53715, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A smarter mask may spot breathing trouble before it starts
- Smart mask alarms may spot breathing trouble before it turns critical
- Heartbeat clues may flag surgery risks in children
- Does a stomach tube prevent breathing problems in babies with pyloric stenosis?
- Common steroid could shield lungs after surgery, but study pulled
- Ultrasound tool may Fine-Tune breathing therapy in hospital patients